Nivasorexant

N/A

Report date: 2024/02/29 17:48:43
NME

Base Information

Drug NameNivasorexant
Drug Alias NameACT-539313SORA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 1 antagonists
TargetsOrexin receptor type 1
Therapy Area/IndicationsBinge-Eating DisorderAnxiety
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermanySwitzerland
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesActelion Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAnxiety
Inactive IndicationsBinge-Eating Disorder

Other Information

ATC CodeN/A
Related LinksN/A